Open access · CC-BY
via OpenAlex
Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons
Gabriela Farias Quipildor, Kai Mao, Pedro J. Beltran, Nir Barzilai, Derek M. Huffman
Diabetes · 2021 · ▲ 20 citations
Abstract
Similar to insulin, central administration of IGF-1 can suppress hepatic glucose production (HGP), but it is unclear whether this effect is mediated via insulin receptors (InsRs) or IGF-1 receptors (IGF-1Rs) in the brain. To this end, we used pharmacologic and genetic approaches in combination with hyperinsulinemic-euglycemic clamps to decipher the role of these receptors in mediating central effects of IGF-1 and insulin on HGP. In rats, we observed that intracerebroventricular (ICV) administration of IGF-1 or insulin markedly increased the glucose infusion rate (GIR) by >50% and suppressed HGP (P < 0.001). However, these effects were completely prevented by preemptive ICV infusion with an IGF-1R and InsR/IGF-1R hybrid (HybridR) blocking antibody. Likewise, ICV infusion of the InsR antagonist, S961, which also can bind HybridRs, interfered with the ability of central insulin, but not IGF-1, to increase the GIR. Furthermore, hyperinsulinemic clamps in mice lacking IGF-1Rs in AgRP neurons revealed ∼30% reduction in the GIR in knockout animals, which was explained by an impaired ability of peripheral insulin to completely suppress HGP (P < 0.05). Signaling studies further revealed an impaired ability of peripheral insulin to trigger ribosomal S6 phosphorylation or phosphatidylinositol (3,4,5)-trisphosphate production in AgRP neurons lacking IGF-1Rs. In summary, these data suggest that attenuation of IGF-1R signaling in the mediobasal hypothalamus, and specifically in AgRP neurons, can phenocopy impaired regulation of HGP as previously demonstrated in mice lacking InsRs in these cells, suggesting a previously unappreciated role for IGF-1Rs and/or HybridRs in the regulation of central insulin/IGF-1 signaling in glucose metabolism.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/db21-0028
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Quipildor, G.F., Mao, K., Beltran, P.J., Barzilai, N., & Huffman, D.M. (2021). Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons. <em>Diabetes</em>. https://doi.org/10.2337/db21-0028
Vancouver
Quipildor GF, Mao K, Beltran PJ, Barzilai N, Huffman DM. Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons. Diabetes. 2021. doi:10.2337/db21-0028.
BibTeX
@article{gabriela2021Modula,
title = {Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons},
author = {Gabriela Farias Quipildor and Kai Mao and Pedro J. Beltran and Nir Barzilai and Derek M. Huffman},
journal = {Diabetes},
year = {2021},
doi = {10.2337/db21-0028},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Inflammation Research 2021
Open access · CC-BY
Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases
Proceedings of the National Academy of Sciences 2007
Preprint · OA
Tissue entrainment by feedback regulation of insulin gene expression in the endoderm of Caenorhabditis elegans
Cellular and Molecular Life Sciences 2005
Preprint · OA
The role of insulin and IGF-1 signaling in longevity
Biomedicines 2023
Open access · CC-BY
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Non-cell-autonomous regulation of germline proteostasis by insulin/IGF-1 signaling via the intestinal peptide transporter PEPT-1
Journal of biochemical and molecular toxicology 2026
Open access · OA